Detection and Quantification of the Capsular Polysaccharide of Burkholderia pseudomallei in Serum and Urine Samples from Melioidosis Patients

Haley L. DeMers, Teerapat Nualnoi, Peter Thorkildson, Derrick Hau, Emily E. Hannah, Heather R. Green, Sujata G. Pandit, Marcellene A. Gates‐Hollingsworth, Latsaniphone Boutthasavong, Manophab Luangraj,

Microbiology Spectrum · 2022 · 11 citations · 22 references

DOIFull text

Open access

Concepts

Abstract

Melioidosis is very challenging to diagnose. There is a clear need for a point-of-care assay for the detection of B. pseudomallei antigen directly from patient samples. The Active Melioidosis Detect lateral flow immunoassay detects the capsular polysaccharide (CPS) of B. pseudomallei and is designed for use on various clinical samples, including serum and urine. However, there are limited data regarding which clinical matrix is preferable for the detection of CPS. This study addresses this question by examining quantitative CPS levels in paired serum and urine samples and relating them to clinical parameters. Additionally, centrifugal concentration was performed on a subset of urine samples to determine whether this might enable the detection of CPS in samples in which it was initially present at low or undetectable levels. These results provide valuable insights into the detection of CPS in patients with melioidosis and suggest potential ways forward in the diagnosis and treatment of this challenging disease.

References

22